Pharmaceutical Information |
Drug Name |
Cefpodoxime |
Drug ID |
BADD_D00395 |
Description |
Cefpodoxime is an oral third generation cephalosporin antibiotic with effectiveness against most Gram positive and Gram negative bacteria. Commonly used to treat acute otitis media, pharyngitis, and sinusitis, cefpodoxime proxetil is a prodrug which is absorbed and de-esterified by the intestinal mucosa to Cefpodoxime. |
Indications and Usage |
Indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms. |
Marketing Status |
approved; vet_approved |
ATC Code |
J01DD13 |
DrugBank ID |
DB01416
|
KEGG ID |
D07650
|
MeSH ID |
C053268
|
PubChem ID |
6335986
|
TTD Drug ID |
D0W6CA
|
NDC Product Code |
Not Available |
UNII |
7R4F94TVGY
|
Synonyms |
cefpodoxime | U 76253A | U-76,253A | RU 51746 | RU-51746 | R 3746 | R-3746 | R 3763 | R-3763 |
|
Chemical Information |
Molecular Formula |
C15H17N5O6S2 |
CAS Registry Number |
80210-62-4 |
SMILES |
COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O |
Chemical Structure |
|
|
ADRs Induced by Drug |
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|